Author

Seok Chan Cho

Yonsei UniversityORCID 0009-0004-7764-2017Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Jongwan KimiD· 2 shared Kyoung Tai NoiD· 2 shared Dong Woo SoniD· 1 shared Dong-Hyeon Kim· 1 shared Donghyuk ShiniD· 1 shared Dongkyu JeoniD· 1 shared Eun A LeeiD· 1 shared Eunyoung Jung· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jongwan KimORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting Noncanonical TEAD Axis to Overcome DNA Repair-Driven Chemoresistance

Dong-Hyeon Kim, Jongwan Kim, Sangwoo Kang, Hwa-Ryeon Kim, Seok Chan Cho, Haiyan Jin, Inyoung Kim, Eunyoung Jung, Hye-Ran Seo, Eun A Lee, Jung‐Soon Mo, Ho Chul Kang, Kyungjae Myung, Jongbum Kwon, Yonghwan Kim, , Hak Park

This study identifies a noncanonical role of TEAD in DNA repair, showing it can be targeted to overcome chemoresistance in tumors.

bioRxiv · Apr 13, 2026 · PreprintCancer Biology

Nutrient availability dictates cancer metabolism-based therapeutic responses of non-oncology drugs

Woo Yang Pyun, Jae Hyung Park, Jae Won Roh, Dongkyu Jeon, Jongwan Kim, Ji Eun Paik, Seok Chan Cho, So Yeon Park, Hocheol Lim, Hyungwoo Kim, Young Jin Jang, Jae Hoon Lee, Jong Hwa Byun, Dong Woo Son, Soo‐Youl Kim, , Hyun Woo Park

This study introduces CM-SLP, a platform to identify non-oncology drugs that enhance cancer cell death under altered nutrient conditions by targeting metabolic vulnerabilities.

Cancer Research · Nov 25, 2025Peer-reviewedCancer Biology